FFCP PHASE1:Hg19::chr3:13028657..13028672,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=9922 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=29112 | |||
|TSSclassifier=weak | |||
|UniProt= | |||
|association_with_transcript=-121bp_to_ENST00000450726,uc003bxu.3_5end | |||
|coexpression_cluster_id=C50 | |||
|description=CAGE_peak_23_at_IQSEC1_5end | |||
|id=chr3:13028657..13028672,- | |||
|ontology_enrichment_celltype=CL:0002541!2.43e-20!3;CL:0000039!9.49e-09!7;CL:0000586!9.49e-09!7;CL:0000083!2.99e-07!4 | |||
|ontology_enrichment_celltype_v019=CL:0002541;1.06e-27;3!CL:0000039;2.98e-12;7!CL:0000586;2.98e-12;7!CL:0000349;4.24e-10;19 | |||
|ontology_enrichment_celltype_v019_2=CL:0002541,1.06e-27,3;CL:0000039,3.34e-12,7;CL:0000586,3.34e-12,7;CL:0000349,4.30e-10,19 | |||
|ontology_enrichment_development_v019=UBERON:0003124;2.08e-21;1 | |||
|ontology_enrichment_disease=DOID:1799!4.89e-08!1;DOID:10165!4.89e-08!1;DOID:1798!4.89e-08!1;DOID:5093!1.98e-07!4;DOID:1612!1.98e-07!4;DOID:178!2.47e-07!1;DOID:326!2.47e-07!1;DOID:3978!2.47e-07!1;DOID:3394!2.47e-07!1;DOID:5844!2.47e-07!1;DOID:1793!2.99e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:1799;2.08e-21;1!DOID:10165;2.08e-21;1!DOID:1798;2.08e-21;1 | |||
|ontology_enrichment_disease_v019_2=DOID:1799,2.30e-21,1;DOID:10165,2.30e-21,1;DOID:1798,2.30e-21,1 | |||
|ontology_enrichment_uberon=UBERON:0003124!2.55e-23!7;UBERON:0005631!5.06e-22!14;UBERON:0000158!5.06e-22!14;UBERON:0000476!2.43e-20!3;UBERON:0000920!2.43e-20!3;UBERON:0000478!1.75e-12!24;UBERON:0001896!3.69e-09!3;UBERON:0005290!3.69e-09!3;UBERON:0010096!3.69e-09!3;UBERON:0001301!1.39e-07!1;UBERON:0001987!1.69e-07!4;UBERON:0004340!1.69e-07!4 | |||
|ontology_enrichment_uberon_v019=UBERON:0003124;1.06e-27;3!UBERON:0000920;1.06e-27;3!UBERON:0005631;1.40e-18;10!UBERON:0000158;1.40e-18;10!UBERON:0000478;1.08e-13;24 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000920,1.06e-27,3;UBERON:0003124,1.89e-26,7;UBERON:0005631,3.74e-23,14;UBERON:0000158,3.74e-23,14;UBERON:0000478,1.08e-13,24 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.790204397959275,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.604780586659361,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.67906630284078,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.97701981631236,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.43246690842614,0.593929361665277,0,0,0,0,0,0,0,0,0.503865495708552,0,0,0,0,0,0,0,0,0,0,0,0,1.5625665665114,0,0,0,0.254253650292766,0,0,0,0,0,0,0,0.221158519862449,0,0,0,0,0,0,1.38338342632836,2.51321404347362,0.217294743844016,9.57003479195758,0.457987967009312,6.92945208824225,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.19566461893209,0,0,0,0,0,0,0,0,0,0,0,0.284609546029793,0,0,0,0,0.34945333648406,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.262887354279314,0,0,0,0.199679000498991,0,0.446342914883745,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.236417121897595,0.262272940674991,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.573409195690071,0,0.124192805882767,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.59529413996125,0,0,0,0,0,0,0,0,0,0,0.127762427639595,0,0,0,0.455324382702595,7.62840383398694,0,0,0,0,0,0,0.078493092850514,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.245148321753905,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p23@IQSEC1 | |||
}} |
Revision as of 17:28, 21 January 2014
Short description: | p23@IQSEC1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_23_at_IQSEC1_5end |
Coexpression cluster: | C50_chorionic_placenta_amniotic_migratory_smallcell_chronic_choriocarcinoma |
Association with transcript: | -121bp_to_ENST00000450726, uc003bxu.3_5end |
EntrezGene: | IQSEC1 |
HGNC: | 29112 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chorionic membrane mesenchymal stem cell | 1.06e-27 | 3 |
germ line cell | 3.34e-12 | 7 |
germ cell | 3.34e-12 | 7 |
extraembryonic cell | 4.30e-10 | 19 |
Ontology term | p-value | n |
---|---|---|
egg chorion | 1.06e-27 | 3 |
chorion | 1.89e-26 | 7 |
extraembryonic membrane | 3.74e-23 | 14 |
membranous layer | 3.74e-23 | 14 |
extraembryonic structure | 1.08e-13 | 24 |
Ontology term | p-value | n |
---|---|---|
islet cell tumor | 2.30e-21 | 1 |
endocrine pancreas cancer | 2.30e-21 | 1 |
pancreatic endocrine carcinoma | 2.30e-21 | 1 |